Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4783820
Max Phase: Preclinical
Molecular Formula: C45H57N11O8
Molecular Weight: 880.02
Molecule Type: Unknown
Associated Items:
ID: ALA4783820
Max Phase: Preclinical
Molecular Formula: C45H57N11O8
Molecular Weight: 880.02
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(N)=O
Standard InChI: InChI=1S/C45H57N11O8/c1-2-32(40(49)59)52-43(62)36(19-25-14-16-28(57)17-15-25)55-42(61)35(13-7-8-18-46)53-44(63)38(21-27-24-51-34-12-6-4-10-30(27)34)56-45(64)37(54-41(60)31(47)22-39(48)58)20-26-23-50-33-11-5-3-9-29(26)33/h3-6,9-12,14-17,23-24,31-32,35-38,50-51,57H,2,7-8,13,18-22,46-47H2,1H3,(H2,48,58)(H2,49,59)(H,52,62)(H,53,63)(H,54,60)(H,55,61)(H,56,64)/t31-,32?,35-,36-,37-,38-/m0/s1
Standard InChI Key: BBWQAECBEWIJLD-FRKUIUOFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 880.02 | Molecular Weight (Monoisotopic): 879.4392 | AlogP: 0.03 | #Rotatable Bonds: 24 |
Polar Surface Area: 335.53 | Molecular Species: BASE | HBA: 10 | HBD: 12 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.42 | CX Basic pKa: 10.27 | CX LogP: -1.11 | CX LogD: -2.90 |
Aromatic Rings: 5 | Heavy Atoms: 64 | QED Weighted: 0.04 | Np Likeness Score: 0.16 |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):